ADA Partners with DEA on Opioid Epidemic Webinar
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
SoftSmile CEO Khamzat Asabaev explains how the company is addressing the limitations of traditional aligner workflows by uniting treatment planning, CBCT data, and manufacturing into a single, orthodontist-controlled platform.